病毒学应答-话题@MedSci - 梅斯（MedSci）

#病毒学应答#

23篇内容 | 1581人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1967786, encodeId=8c5e196e786e2, content=<a href='/topic/show?id=a981e091928' target=_blank style='color:#2F92EE;'>#病毒学应答#</a>, objectTitle=Cancer：丙型肝炎病毒感染和肝细胞癌患者持续病毒学应答与临床预后的关系, objectType=article, longId=737348, objectId=abbae37348fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abbae37348fc, replyNumber=0, likeNumber=88, createdTime=2022-12-27, rootId=0, userName=nakerunner, userId=0cd7162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abbae37348fc, moduleTitle=Cancer：丙型肝炎病毒感染和肝细胞癌患者持续病毒学应答与临床预后的关系, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=abbae37348fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967785, encodeId=3f56196e78516, content=<a href='/topic/show?id=a981e091928' target=_blank style='color:#2F92EE;'>#病毒学应答#</a>, objectTitle=J Hepatol：HCV肝硬化患者持续病毒学应答后肝脏和非肝脏相关结局的发生率, objectType=article, longId=218539, objectId=57a421853972, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57a421853972, replyNumber=0, likeNumber=107, createdTime=2022-06-08, rootId=0, userName=nakerunner, userId=0cd7162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57a421853972, moduleTitle=J Hepatol：HCV肝硬化患者持续病毒学应答后肝脏和非肝脏相关结局的发生率, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=57a421853972)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967784, encodeId=f21d196e784c8, content=<a href='/topic/show?id=a981e091928' target=_blank style='color:#2F92EE;'>#病毒学应答#</a>, objectTitle=J Gastroenterology：直接作用抗病毒药持续病毒学应答对HCV肝硬化患者胃食管静脉曲张, objectType=article, longId=187606, objectId=e3cd18e60695, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3cd18e60695, replyNumber=0, likeNumber=82, createdTime=2020-05-15, rootId=0, userName=nakerunner, userId=0cd7162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3cd18e60695, moduleTitle=J Gastroenterology：直接作用抗病毒药持续病毒学应答对HCV肝硬化患者胃食管静脉曲张, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e3cd18e60695)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967783, encodeId=b78c196e783da, content=<a href='/topic/show?id=a981e091928' target=_blank style='color:#2F92EE;'>#病毒学应答#</a>, objectTitle=J Hepatology：基于干扰素的丙型肝炎治疗方案持续的病毒学应答与降低肝外表现的风险有关, objectType=article, longId=186949, objectId=a52718694904, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a52718694904, replyNumber=0, likeNumber=90, createdTime=2020-06-19, rootId=0, userName=nakerunner, userId=0cd7162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a52718694904, moduleTitle=J Hepatology：基于干扰素的丙型肝炎治疗方案持续的病毒学应答与降低肝外表现的风险有关, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a52718694904)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967782, encodeId=abdf196e782a8, content=<a href='/topic/show?id=a981e091928' target=_blank style='color:#2F92EE;'>#病毒学应答#</a>, objectTitle=Clin Gastroenterology H：持续病毒学应答对慢性丙型肝炎病毒感染患者的长期益处, objectType=article, longId=186632, objectId=f8e61866328b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8e61866328b, replyNumber=0, likeNumber=73, createdTime=2020-06-03, rootId=0, userName=nakerunner, userId=0cd7162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8e61866328b, moduleTitle=Clin Gastroenterology H：持续病毒学应答对慢性丙型肝炎病毒感染患者的长期益处, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f8e61866328b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967780, encodeId=ecdc196e7806a, content=<a href='/topic/show?id=a981e091928' target=_blank style='color:#2F92EE;'>#病毒学应答#</a>, objectTitle=Gastroenterology：HCV感染引起的与肝癌风险相关的表观遗传改变在持续的病毒学应答后持续存在, objectType=article, longId=163131, objectId=90c11631319d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90c11631319d, replyNumber=0, likeNumber=125, createdTime=2019-05-06, rootId=0, userName=nakerunner, userId=0cd7162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90c11631319d, moduleTitle=Gastroenterology：HCV感染引起的与肝癌风险相关的表观遗传改变在持续的病毒学应答后持续存在, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=90c11631319d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967781, encodeId=3a0b196e781c6, content=<a href='/topic/show?id=a981e091928' target=_blank style='color:#2F92EE;'>#病毒学应答#</a>, objectTitle=聚乙二醇干扰素λ治疗丁型肝炎24周后出现持续病毒学应答, objectType=article, longId=164170, objectId=e28a1641e0ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e28a1641e0ba, replyNumber=0, likeNumber=93, createdTime=2020-01-03, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e28a1641e0ba, moduleTitle=聚乙二醇干扰素λ治疗丁型肝炎24周后出现持续病毒学应答, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e28a1641e0ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967779, encodeId=7e55196e779dd, content=<a href='/topic/show?id=a981e091928' target=_blank style='color:#2F92EE;'>#病毒学应答#</a>, objectTitle=AP&T：对丙型肝炎治疗的持续病毒学应答降低了与2型糖尿病相关的并发症的发生率, objectType=article, longId=160234, objectId=2e3216023442, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e3216023442, replyNumber=0, likeNumber=100, createdTime=2019-08-05, rootId=0, userName=nakerunner, userId=0cd7162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e3216023442, moduleTitle=AP&T：对丙型肝炎治疗的持续病毒学应答降低了与2型糖尿病相关的并发症的发生率, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2e3216023442)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967776, encodeId=a6be196e776d1, content=<a href='/topic/show?id=a981e091928' target=_blank style='color:#2F92EE;'>#病毒学应答#</a>, objectTitle=Hepatol Res：基线维生素D水平与慢性乙型肝炎患者遗传决定因素和病毒学应答的相关性, objectType=article, longId=132814, objectId=ceeb13281407, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ceeb13281407, replyNumber=0, likeNumber=86, createdTime=2019-01-05, rootId=0, userName=nakerunner, userId=0cd7162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ceeb13281407, moduleTitle=Hepatol Res：基线维生素D水平与慢性乙型肝炎患者遗传决定因素和病毒学应答的相关性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ceeb13281407)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967777, encodeId=4032196e7777f, content=<a href='/topic/show?id=a981e091928' target=_blank style='color:#2F92EE;'>#病毒学应答#</a>, objectTitle=J Viral Hepat肝硬化、高龄、较高的身体质量指数是获得持续病毒学应答的慢性丙型肝炎患者的危险因素, objectType=article, longId=135563, objectId=10cc1355633a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10cc1355633a, replyNumber=0, likeNumber=91, createdTime=2018-05-15, rootId=0, userName=nakerunner, userId=0cd7162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10cc1355633a, moduleTitle=J Viral Hepat肝硬化、高龄、较高的身体质量指数是获得持续病毒学应答的慢性丙型肝炎患者的危险因素, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=10cc1355633a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967778, encodeId=0241196e778d8, content=<a href='/topic/show?id=a981e091928' target=_blank style='color:#2F92EE;'>#病毒学应答#</a>, objectTitle=J Viral Hepat：肝硬化、高龄、较高的BMI是获得可持续病毒学应答的晚期肝纤维化HCV患者的危险因素, objectType=article, longId=142592, objectId=cd51142592a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd51142592a7, replyNumber=0, likeNumber=80, createdTime=2018-07-09, rootId=0, userName=nakerunner, userId=0cd7162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd51142592a7, moduleTitle=J Viral Hepat：肝硬化、高龄、较高的BMI是获得可持续病毒学应答的晚期肝纤维化HCV患者的危险因素, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cd51142592a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967775, encodeId=4c0c196e775e4, content=<a href='/topic/show?id=a981e091928' target=_blank style='color:#2F92EE;'>#病毒学应答#</a>, objectTitle=Hepatology：持续病毒学应答对肝病患者的影响如何？, objectType=article, longId=128778, objectId=115f128e78a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=115f128e78a5, replyNumber=0, likeNumber=81, createdTime=2018-10-26, rootId=0, userName=nakerunner, userId=0cd7162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=115f128e78a5, moduleTitle=Hepatology：持续病毒学应答对肝病患者的影响如何？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=115f128e78a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967773, encodeId=f339196e7737e, content=<a href='/topic/show?id=a981e091928' target=_blank style='color:#2F92EE;'>#病毒学应答#</a>, objectTitle=Hepatol：晚期肝病患者接受直接抗病毒药物治疗获得持续病毒学应答后对死亡率的影响, objectType=article, longId=110601, objectId=5ce811060188, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ce811060188, replyNumber=0, likeNumber=75, createdTime=2017-11-17, rootId=0, userName=nakerunner, userId=0cd7162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ce811060188, moduleTitle=Hepatol：晚期肝病患者接受直接抗病毒药物治疗获得持续病毒学应答后对死亡率的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5ce811060188)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967774, encodeId=58c4196e77497, content=<a href='/topic/show?id=a981e091928' target=_blank style='color:#2F92EE;'>#病毒学应答#</a>, objectTitle=SCI REP：循环miR-210和miR-22结合ALT预测慢性乙型肝炎患者进行IFN-α治疗的病毒学应答!, objectType=article, longId=120238, objectId=b0771202389f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0771202389f, replyNumber=0, likeNumber=64, createdTime=2018-10-13, rootId=0, userName=nakerunner, userId=0cd7162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0771202389f, moduleTitle=SCI REP：循环miR-210和miR-22结合ALT预测慢性乙型肝炎患者进行IFN-α治疗的病毒学应答!, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b0771202389f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967772, encodeId=ea93196e77229, content=<a href='/topic/show?id=a981e091928' target=_blank style='color:#2F92EE;'>#病毒学应答#</a>, objectTitle=J Hepatol：在使用富马酸替诺福韦二吡呋酯（TDF）取得长期病毒学应答的非肝硬化的e抗原阴性的慢乙肝患者中停药的研究——FINITE研究, objectType=article, longId=106882, objectId=61e910688226, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61e910688226, replyNumber=0, likeNumber=80, createdTime=2018-07-02, rootId=0, userName=nakerunner, userId=0cd7162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61e910688226, moduleTitle=J Hepatol：在使用富马酸替诺福韦二吡呋酯（TDF）取得长期病毒学应答的非肝硬化的e抗原阴性的慢乙肝患者中停药的研究——FINITE研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=61e910688226)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967771, encodeId=6cc0196e77154, content=<a href='/topic/show?id=a981e091928' target=_blank style='color:#2F92EE;'>#病毒学应答#</a>, objectTitle=J Hepatol：持续病毒学应答对肝癌风险的影响, objectType=article, longId=82159, objectId=e6798215914, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6798215914, replyNumber=0, likeNumber=83, createdTime=2017-04-23, rootId=0, userName=nakerunner, userId=0cd7162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6798215914, moduleTitle=J Hepatol：持续病毒学应答对肝癌风险的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e6798215914)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967770, encodeId=7261196e770b2, content=<a href='/topic/show?id=a981e091928' target=_blank style='color:#2F92EE;'>#病毒学应答#</a>, objectTitle=NEJM：Sofosbuvir和Velpatasvir治疗HCV感染有较高的病毒学应答率, objectType=article, longId=58934, objectId=42b75893460, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42b75893460, replyNumber=0, likeNumber=89, createdTime=2016-03-09, rootId=0, userName=nakerunner, userId=0cd7162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42b75893460, moduleTitle=NEJM：Sofosbuvir和Velpatasvir治疗HCV感染有较高的病毒学应答率, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=42b75893460)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967769, encodeId=a7b0196e769ba, content=<a href='/topic/show?id=a981e091928' target=_blank style='color:#2F92EE;'>#病毒学应答#</a>, objectTitle=NEJM：Ledipasvir/Sofosbuvir治疗提高了HIV-1/HCV共感染患者的持续病毒学应答率, objectType=article, longId=53683, objectId=f61b53683e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f61b53683e0, replyNumber=0, likeNumber=66, createdTime=2015-08-17, rootId=0, userName=nakerunner, userId=0cd7162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f61b53683e0, moduleTitle=NEJM：Ledipasvir/Sofosbuvir治疗提高了HIV-1/HCV共感染患者的持续病毒学应答率, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f61b53683e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967768, encodeId=0ab8196e76873, content=<a href='/topic/show?id=a981e091928' target=_blank style='color:#2F92EE;'>#病毒学应答#</a>, objectTitle=EASL 2014：NUCs与IFN联合序贯治疗提高慢乙肝病毒学应答率, objectType=article, longId=33344, objectId=40aa3334452, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40aa3334452, replyNumber=0, likeNumber=85, createdTime=2014-12-08, rootId=0, userName=nakerunner, userId=0cd7162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40aa3334452, moduleTitle=EASL 2014：NUCs与IFN联合序贯治疗提高慢乙肝病毒学应答率, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=40aa3334452)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967767, encodeId=e15e196e76700, content=<a href='/topic/show?id=a981e091928' target=_blank style='color:#2F92EE;'>#病毒学应答#</a>, objectTitle=JAMA：Sofosbuvir+利巴韦林可用于治疗病毒学应答不佳的基因1型慢性丙型肝炎患者, objectType=article, longId=24013, objectId=837d240139b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=837d240139b, replyNumber=0, likeNumber=73, createdTime=2014-08-15, rootId=0, userName=nakerunner, userId=0cd7162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=837d240139b, moduleTitle=JAMA：Sofosbuvir+利巴韦林可用于治疗病毒学应答不佳的基因1型慢性丙型肝炎患者, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=837d240139b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

病毒学应答

2020-05-29

nakerunner (审核中...)

前往app查看评论内容

#病毒学应答#

Cancer：丙型肝炎病毒感染和肝细胞癌患者持续病毒学应答与临床预后的关系

2022-12-27

nakerunner (审核中...)

前往app查看评论内容

#病毒学应答#

J Hepatol：HCV肝硬化患者持续病毒学应答后肝脏和非肝脏相关结局的发生率

2022-06-08

nakerunner (审核中...)

前往app查看评论内容

#病毒学应答#

J Gastroenterology：直接作用抗病毒药持续病毒学应答对HCV肝硬化患者胃食管静脉曲张

2020-05-15

nakerunner (审核中...)

前往app查看评论内容

#病毒学应答#

J Hepatology：基于干扰素的丙型肝炎治疗方案持续的病毒学应答与降低肝外表现的风险有关

2020-06-19

nakerunner (审核中...)

前往app查看评论内容

#病毒学应答#

Clin Gastroenterology H：持续病毒学应答对慢性丙型肝炎病毒感染患者的长期益处

2020-06-03

nakerunner (审核中...)

前往app查看评论内容

#病毒学应答#

Gastroenterology：HCV感染引起的与肝癌风险相关的表观遗传改变在持续的病毒学应答后持续存在

2019-05-06

仁者大医 (审核中...)

前往app查看评论内容

#病毒学应答#

聚乙二醇干扰素λ治疗丁型肝炎24周后出现持续病毒学应答

2020-01-03

nakerunner (审核中...)

前往app查看评论内容

#病毒学应答#

AP&T：对丙型肝炎治疗的持续病毒学应答降低了与2型糖尿病相关的并发症的发生率

2019-08-05

nakerunner (审核中...)

前往app查看评论内容

#病毒学应答#

Hepatol Res：基线维生素D水平与慢性乙型肝炎患者遗传决定因素和病毒学应答的相关性

2019-01-05

nakerunner (审核中...)

前往app查看评论内容

#病毒学应答#

J Viral Hepat肝硬化、高龄、较高的身体质量指数是获得持续病毒学应答的慢性丙型肝炎患者的危险因素

2018-05-15

nakerunner (审核中...)

前往app查看评论内容

#病毒学应答#

J Viral Hepat：肝硬化、高龄、较高的BMI是获得可持续病毒学应答的晚期肝纤维化HCV患者的危险因素

2018-07-09

nakerunner (审核中...)

前往app查看评论内容

#病毒学应答#

Hepatology：持续病毒学应答对肝病患者的影响如何？

2018-10-26

nakerunner (审核中...)

前往app查看评论内容

#病毒学应答#

Hepatol：晚期肝病患者接受直接抗病毒药物治疗获得持续病毒学应答后对死亡率的影响

2017-11-17

nakerunner (审核中...)

前往app查看评论内容

#病毒学应答#

SCI REP：循环miR-210和miR-22结合ALT预测慢性乙型肝炎患者进行IFN-α治疗的病毒学应答!

2018-10-13

nakerunner (审核中...)

前往app查看评论内容

#病毒学应答#

J Hepatol：在使用富马酸替诺福韦二吡呋酯（TDF）取得长期病毒学应答的非肝硬化的e抗原阴性的慢乙肝患者中停药的研究——FINITE研究

2018-07-02

nakerunner (审核中...)

前往app查看评论内容

#病毒学应答#

J Hepatol：持续病毒学应答对肝癌风险的影响

2017-04-23

nakerunner (审核中...)

前往app查看评论内容

#病毒学应答#

NEJM：Sofosbuvir和Velpatasvir治疗HCV感染有较高的病毒学应答率

2016-03-09

nakerunner (审核中...)

前往app查看评论内容

#病毒学应答#

NEJM：Ledipasvir/Sofosbuvir治疗提高了HIV-1/HCV共感染患者的持续病毒学应答率

2015-08-17

nakerunner (审核中...)

前往app查看评论内容

#病毒学应答#

EASL 2014：NUCs与IFN联合序贯治疗提高慢乙肝病毒学应答率

2014-12-08

nakerunner (审核中...)

前往app查看评论内容

#病毒学应答#

JAMA：Sofosbuvir+利巴韦林可用于治疗病毒学应答不佳的基因1型慢性丙型肝炎患者

2014-08-15

科室
- - 订阅+
  - 更多科室
工具
服务